Do you see any chance that if P3 holistically fails, the drug could still get approved for a more limited clinical approach, like PCV or occult? In footy terms, if P3 doesn’t kick a goal, could we at least get a point instead of being out of bounds on the full? What do you think?
Do you see any chance that if P3 holistically fails, the drug...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.5¢ |
Change
-0.010(1.24%) |
Mkt cap ! $978.7M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 81.0¢ | 78.8¢ | $1.042M | 1.308M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1823 | 79.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 22000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |